Reduction of serum cholesterol and triglyceride levels by the combined administration of neomycin and clofibrate.
D000293:Adolescent; D000328:Adult; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001161:Arteriosclerosis / Q000188:drug therapy; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000008:administration & dosage / Q000494:pharmacology; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009355:Neomycin / Q000008:administration & dosage / Q000494:pharmacology*; D011422:Propionates / Q000494:pharmacology*; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D011422:Propionates; D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate; D009355:Neomycin